Exploring the challenges of AI-driven business intelligence systems in the Malaysian insurance industry.

Q2 Pharmacology, Toxicology and Pharmaceutics
F1000Research Pub Date : 2025-04-22 eCollection Date: 2025-01-01 DOI:10.12688/f1000research.163354.1
Sharmila Ramachandaran, Zubaidi Mahalley, Riska Nuraini, Bablu Kumar Dhar
{"title":"Exploring the challenges of AI-driven business intelligence systems in the Malaysian insurance industry.","authors":"Sharmila Ramachandaran, Zubaidi Mahalley, Riska Nuraini, Bablu Kumar Dhar","doi":"10.12688/f1000research.163354.1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Integrating Artificial Intelligence (AI) with Business Intelligence (BI) systems in the insurance industry holds the potential for enhanced operational efficiency, strategic decision-making, and improved customer experiences. However, the Malaysian insurance sector faces numerous challenges in realizing this potential, including organizational resistance, skill shortages, regulatory complexities, and financial constraints. This study explores the specific challenges encountered in the adoption of AI-driven BI systems within the Malaysian insurance industry.</p><p><strong>Methods: </strong>Using an integrated framework that combines the Technology-Organization-Environment (TOE) model and Resource-Based View (RBV), this research examines the internal and external factors that impact AI adoption. A qualitative case study approach was employed, involving in-depth interviews with technical experts, middle management, and senior leaders from key industry players. Thematic analysis of the data identified significant barriers to AI adoption, such as organizational resistance, lack of skilled personnel, and the complexities of navigating regulatory frameworks.</p><p><strong>Results: </strong>The findings provide a deep understanding of the key challenges faced by Malaysian insurers and highlight areas that require attention, such as leadership commitment, workforce upskilling, technological infrastructure improvements, and policy advocacy.</p><p><strong>Conclusion: </strong>This study adds to the limited academic literature on AI-driven BI adoption in emerging markets and offers practical insights to insurers for overcoming these challenges. By addressing these obstacles, this research contributes to the broader discourse on digital transformation in the insurance sector, offering valuable recommendations for overcoming hurdles in AI adoption while maintaining compliance and ensuring customer-centric approaches.</p>","PeriodicalId":12260,"journal":{"name":"F1000Research","volume":"14 ","pages":"452"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198725/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F1000Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/f1000research.163354.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Integrating Artificial Intelligence (AI) with Business Intelligence (BI) systems in the insurance industry holds the potential for enhanced operational efficiency, strategic decision-making, and improved customer experiences. However, the Malaysian insurance sector faces numerous challenges in realizing this potential, including organizational resistance, skill shortages, regulatory complexities, and financial constraints. This study explores the specific challenges encountered in the adoption of AI-driven BI systems within the Malaysian insurance industry.

Methods: Using an integrated framework that combines the Technology-Organization-Environment (TOE) model and Resource-Based View (RBV), this research examines the internal and external factors that impact AI adoption. A qualitative case study approach was employed, involving in-depth interviews with technical experts, middle management, and senior leaders from key industry players. Thematic analysis of the data identified significant barriers to AI adoption, such as organizational resistance, lack of skilled personnel, and the complexities of navigating regulatory frameworks.

Results: The findings provide a deep understanding of the key challenges faced by Malaysian insurers and highlight areas that require attention, such as leadership commitment, workforce upskilling, technological infrastructure improvements, and policy advocacy.

Conclusion: This study adds to the limited academic literature on AI-driven BI adoption in emerging markets and offers practical insights to insurers for overcoming these challenges. By addressing these obstacles, this research contributes to the broader discourse on digital transformation in the insurance sector, offering valuable recommendations for overcoming hurdles in AI adoption while maintaining compliance and ensuring customer-centric approaches.

探索人工智能驱动的商业智能系统在马来西亚保险业面临的挑战。
背景:将人工智能(AI)与商业智能(BI)系统集成在保险业中,可以提高运营效率、战略决策和改善客户体验。然而,马来西亚保险部门在实现这一潜力方面面临着许多挑战,包括组织阻力、技能短缺、监管复杂性和资金限制。本研究探讨了马来西亚保险业采用人工智能驱动的BI系统所遇到的具体挑战。方法:采用结合技术-组织-环境(TOE)模型和资源基础视图(RBV)的集成框架,本研究考察了影响人工智能采用的内部和外部因素。采用了定性案例研究方法,包括对来自主要行业参与者的技术专家、中层管理人员和高级领导进行深入访谈。数据的专题分析确定了人工智能采用的重大障碍,例如组织阻力、缺乏熟练人员以及驾驭监管框架的复杂性。结果:调查结果提供了对马来西亚保险公司面临的主要挑战的深刻理解,并突出了需要关注的领域,如领导承诺、劳动力技能提升、技术基础设施改善和政策倡导。结论:本研究补充了关于新兴市场采用人工智能驱动的商业智能的有限学术文献,并为保险公司克服这些挑战提供了实际见解。通过解决这些障碍,本研究有助于保险业数字化转型的更广泛讨论,为克服人工智能采用中的障碍,同时保持合规性和确保以客户为中心的方法提供有价值的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
F1000Research
F1000Research Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.00
自引率
0.00%
发文量
1646
审稿时长
1 weeks
期刊介绍: F1000Research publishes articles and other research outputs reporting basic scientific, scholarly, translational and clinical research across the physical and life sciences, engineering, medicine, social sciences and humanities. F1000Research is a scholarly publication platform set up for the scientific, scholarly and medical research community; each article has at least one author who is a qualified researcher, scholar or clinician actively working in their speciality and who has made a key contribution to the article. Articles must be original (not duplications). All research is suitable irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies. F1000Research publishes different type of research, including clinical trials, systematic reviews, software tools, method articles, and many others. Reviews and Opinion articles providing a balanced and comprehensive overview of the latest discoveries in a particular field, or presenting a personal perspective on recent developments, are also welcome. See the full list of article types we accept for more information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信